** 23andMe Restructures, Cutting 40% of Staff Amid Financial Challenges

The genetic testing company 23andMe has announced a significant restructuring effort, resulting in the elimination of approximately 200 jobs (40% of its workforce). This move follows a tumultuous year for the company, including a cyberattack that compromised data on millions of users and leadership shake-ups. The company aims to focus on its core consumer business and research partnerships while discontinuing its therapeutics business.

**

Source: https://techcrunch.com/2024/11/12/23andme-cuts-40-of-staff-in-restructuring/